Praxis Precision Medicines Inc. (PRAX) PT Raised to $175 at Truist; 'Incrementally Positive On Ph3 ESSENTIAL3'
Tweet Send to a Friend
Truist Securities analyst Joon Lee raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
